Intestinal antibody responses after immunisation with cholera B subunit - PubMed (original) (raw)
Clinical Trial
Intestinal antibody responses after immunisation with cholera B subunit
A M Svennerholm et al. Lancet. 1982.
Abstract
In about 80% of Bangladeshi volunteers a single oral or intramuscular immunisation with a new cholera toxoid immunogen (B subunit) gave rise to a local intestinal secretory immunoglobulin A (IgA) antitoxin response as measured in intestinal-lavage fluid by enzyme-linked immunosorbent assay methods. The rise in IgA antitoxin titre was similar for both immunisation routes and was comparable to that seen after clinical cholera; however, the response persisted longer after oral than intramuscular immunisation. A second immunisation by either route evoked an antitoxin response which usually closely resembled that seen after the first immunisation.
Similar articles
- Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes.
Svennerholm AM, Gothefors L, Sack DA, Bardhan PK, Holmgren J. Svennerholm AM, et al. Bull World Health Organ. 1984;62(6):909-18. Bull World Health Organ. 1984. PMID: 6335849 Free PMC article. - Protection against experimental cholera by oral or parenteral immunization.
Peterson JW. Peterson JW. Infect Immun. 1979 Nov;26(2):594-8. doi: 10.1128/iai.26.2.594-598.1979. Infect Immun. 1979. PMID: 546789 Free PMC article. - Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
Svennerholm AM, Jertborn M, Gothefors L, Karim AM, Sack DA, Holmgren J. Svennerholm AM, et al. J Infect Dis. 1984 Jun;149(6):884-93. doi: 10.1093/infdis/149.6.884. J Infect Dis. 1984. PMID: 6736680 - Current status of an oral B subunit whole cell cholera vaccine.
Svennerholm AM, Jertborn M, Gothefors L, Karim A, Sack DA, Holmgren J. Svennerholm AM, et al. Dev Biol Stand. 1983;53:73-9. Dev Biol Stand. 1983. PMID: 6873479 - Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Holmgren J, et al. Am J Trop Med Hyg. 1994;50(5 Suppl):42-54. Am J Trop Med Hyg. 1994. PMID: 8203723 Review.
Cited by
- Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.
Johansson EL, Wassén L, Holmgren J, Jertborn M, Rudin A. Johansson EL, et al. Infect Immun. 2001 Dec;69(12):7481-6. doi: 10.1128/IAI.69.12.7481-7486.2001. Infect Immun. 2001. PMID: 11705923 Free PMC article. - Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
Liang W, Wang S, Yu F, Zhang L, Qi G, Liu Y, Gao S, Kan B. Liang W, et al. Infect Immun. 2003 Oct;71(10):5498-504. doi: 10.1128/IAI.71.10.5498-5504.2003. Infect Immun. 2003. PMID: 14500467 Free PMC article. - Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains.
Butterton JR, Ryan ET, Acheson DW, Calderwood SB. Butterton JR, et al. Infect Immun. 1997 Jun;65(6):2127-35. doi: 10.1128/iai.65.6.2127-2135.1997. Infect Immun. 1997. PMID: 9169742 Free PMC article. - New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.
Levine MM, Kaper JB, Black RE, Clements ML. Levine MM, et al. Microbiol Rev. 1983 Dec;47(4):510-50. doi: 10.1128/mr.47.4.510-550.1983. Microbiol Rev. 1983. PMID: 6363898 Free PMC article. Review. - Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.
Jacob CO, Sela M, Pines M, Hurwitz S, Arnon R. Jacob CO, et al. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7893-6. doi: 10.1073/pnas.81.24.7893. Proc Natl Acad Sci U S A. 1984. PMID: 6595665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous